Utilization of alverine, alone or in combination with tricyclic antidepressant or a specific serotonin reuptake inhibitor for the treatment of depression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 24, 2005
app pub date -
Jun 14, 2004
filing date -
Jun 13, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention relates to the utilization of Alverine or its metabolites, alone or in combination with a tricyclic antidepressant or a specific serotonin reuptake inhibitor, for the preparation of pharmaceutical compositions for the treatment of depression.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully